Blockade of glucagon-like peptide 1 receptor corrects postprandial hypoglycemia after gastric bypass

Gastroenterology

Volumn 146, Issue 3, 2014, Pages

  Salehi, Marzieh ^a   Gastaldelli, Amalia ^b   D'Alessio, David A ^a,c  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Glucagon like Peptide 1; Hyperinsulinemic Hypoglycemia Syndrome; Islet Function; Roux en Y Gastric Bypass Surgery

Indexed keywords

EXENDIN 4; GLUCAGON; GLUCAGON LIKE PEPTIDE 1 RECEPTOR; GLUCOSE; INSULIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTINUOUS INFUSION; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE TRANSPORT; HORMONE RESPONSE; HUMAN; HYPERINSULINEMIA; HYPERINSULINEMIC HYPOGLYCEMIC SYNDROME; HYPOGLYCEMIA; INSULIN RELEASE; MALE; PANCREAS ISLET; POSTPRANDIAL STATE; PRIORITY JOURNAL; ROUX Y ANASTOMOSIS; STOMACH BYPASS; TEST MEAL;

GLUCAGON-LIKE PEPTIDE 1; HYPERINSULINEMIC HYPOGLYCEMIA SYNDROME; ISLET FUNCTION; ROUX-EN-Y GASTRIC BYPASS SURGERY;

ADULT; BLOOD GLUCOSE; CASE-CONTROL STUDIES; FEMALE; GASTRIC BYPASS; GLUCAGON; GLUCAGON-LIKE PEPTIDE 1; GLUCAGON-SECRETING CELLS; HUMANS; HYPOGLYCEMIA; INSULIN; INSULIN-SECRETING CELLS; MALE; MIDDLE AGED; PEPTIDE FRAGMENTS; RECEPTORS, GLUCAGON; TREATMENT OUTCOME;

EID: 84894293729     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2013.11.044     Document Type: Article

References (38)

1. F. Rodieux, V. Giusti, and D.A. D'Alessio et al. Effects of gastric bypass and gastric banding on glucose kinetics and gut hormone release Obesity (Silver Spring) 16 2008 298 305
2. S.H. Jacobsen, K.N. Bojsen-Moller, and C. Dirksen et al. Effects of gastric bypass surgery on glucose absorption and metabolism during a mixed meal in glucose-tolerant individuals Diabetologia 56 2013 2250 2254
3. N.B. Jorgensen, S.H. Jacobsen, and C. Dirksen et al. Acute and long-term effects of Roux-en-Y gastric bypass on glucose metabolism in subjects with type 2 diabetes and normal glucose tolerance Am J Physiol Endocrinol Metab 303 2012 E122 E131
4. J. Schirra, M. Katschinski, and C. Weidmann et al. Gastric emptying and release of incretin hormones after glucose ingestion in humans J Clin Invest 97 1996 92 103
5. R. Chaikomin, S. Doran, and K.L. Jones et al. Initially more rapid small intestinal glucose delivery increases plasma insulin, GIP, and GLP-1 but does not improve overall glycemia in healthy subjects Am J Physiol Endocrinol Metab 289 2005 E504 E507
6. M. Salehi, R.L. Prigeon, and D.A. D'Alessio Gastric bypass surgery enhances glucagon-like Peptide 1-stimulated postprandial insulin secretion in humans Diabetes 60 2011 2308 2314
7. M.E. Patti, G. McMahon, and E.C. Mun et al. Severe hypoglycaemia post-gastric bypass requiring partial pancreatectomy: evidence for inappropriate insulin secretion and pancreatic islet hyperplasia Diabetologia 48 2005 2236 2240
8. G.J. Service, G.B. Thompson, and F.J. Service et al. Hyperinsulinemic hypoglycemia with nesidioblastosis after gastric-bypass surgery N Engl J Med 353 2005 249 254
9. A.B. Goldfine, E.C. Mun, and E. Devine et al. Patients with neuroglycopenia after gastric bypass surgery have exaggerated incretin and insulin secretory responses to a mixed meal J Clin Endocrinol Metab 92 2007 4678 4685
10. J.J. Meier, A.E. Butler, and R. Galasso et al. Hyperinsulinemic hypoglycemia after gastric bypass surgery is not accompanied by islet hyperplasia or increased beta-cell turnover Diabetes Care 29 2006 1554 1559
11. P.E. Cryer, L. Axelrod, and A.B. Grossman et al. Evaluation and management of adult hypoglycemic disorders: an Endocrine Society Clinical Practice Guideline J Clin Endocrinol Metab 94 2009 709 728
12. H. Sigstad A clinical diagnostic index in the diagnosis of the dumping syndrome. Changes in plasma volume and blood sugar after a test meal Acta Med Scand 188 1970 479 486
13. S. Camastra, A. Gastaldelli, and A. Mari et al. Early and longer term effects of gastric bypass surgery on tissue-specific insulin sensitivity and beta cell function in morbidly obese patients with and without type 2 diabetes Diabetologia 54 2011 2093 2102
14. M. Salehi, B. Aulinger, and R.L. Prigeon et al. Effect of endogenous GLP-1 on insulin secretion in type 2 diabetes Diabetes 59 2010 1330 1337
15. M. Salehi, T.P. Vahl, and D.A. D'Alessio Regulation of islet hormone release and gastric emptying by endogenous glucagon-like peptide 1 after glucose ingestion J Clin Endocrinol Metab 93 2008 4909 4916
16. E. Van Cauter, F. Mestrez, and J. Sturis et al. Estimation of insulin secretion rates from C-peptide levels. Comparison of individual and standard kinetic parameters for C-peptide clearance Diabetes 41 1992 368 377
17. A. Gastaldelli, A. Casolaro, and M. Pettiti et al. Effect of pioglitazone on the metabolic and hormonal response to a mixed meal in type II diabetes Clin Pharmacol Ther 81 2007 205 212
18. R. Steele, C. Bjerknes, and I. Rathgeb et al. Glucose uptake and production during the oral glucose tolerance test Diabetes 17 1968 415 421
19. R. Steele Influences of glucose loading and of injected insulin on hepatic glucose output Ann N Y Acad Sci 82 1959 420 430
20. L.T. Shuster, V.L. Go, and R.A. Rizza et al. Incretin effect due to increased secretion and decreased clearance of insulin in normal humans Diabetes 37 1988 200 203
21. H. Tillil, E.T. Shapiro, and M.A. Miller et al. Dose-dependent effects of oral and intravenous glucose on insulin secretion and clearance in normal humans Am J Physiol 254 1988 E349 E357
22. A. Gastaldelli, R.G. Brodows, and D. D'Alessio The effect of chronic twice daily exenatide treatment on beta-cell function in new onset type 2 diabetes Clin Endocrinol (Oxf) 2013 Mar 14 [Epub ahead of print]
23. A. Mari, O. Schmitz, and A. Gastaldelli et al. Meal and oral glucose tests for assessment of beta -cell function: modeling analysis in normal subjects Am J Physiol Endocrinol Metab 283 2002 E1159 E1166
24. D.R. Matthews, J.P. Hosker, and A.S. Rudenski et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man Diabetologia 28 1985 412 419
25. A. Mari, M. Manco, and C. Guidone et al. Restoration of normal glucose tolerance in severely obese patients after bilio-pancreatic diversion: role of insulin sensitivity and beta cell function Diabetologia 49 2006 2136 2143
26. A. Gastaldelli, M.A. Nauck, and R. Balena Eight weeks of treatment with long-acting GLP-1 analog taspoglutide improves postprandial insulin secretion and sensitivity in metformin-treated patients with type 2 diabetes Metabolism 62 2013 1330 1339
27. R. Morinigo, V. Moize, and M. Musri et al. Glucagon-like peptide-1, peptide YY, hunger, and satiety after gastric bypass surgery in morbidly obese subjects J Clin Endocrinol Metab 91 2006 1735 1740
28. M. Horowitz, P.J. Collins, and P.E. Harding et al. Gastric emptying after gastric bypass Int J Obes 10 1986 117 121
29. M. Horowitz, D.J. Cook, and P.J. Collins et al. Measurement of gastric emptying after gastric bypass surgery using radionuclides Br J Surg 69 1982 655 657
30. C. Dirksen, M. Damgaard, and K.N. Bojsen-Moller et al. Fast pouch emptying, delayed small intestinal transit, and exaggerated gut hormone responses after Roux-en-Y gastric bypass Neurogastroenterol Motil 25 2013 346-e255
31. M.C. Moore, K.C. Coate, and J.J. Winnick et al. Regulation of hepatic glucose uptake and storage in vivo Adv Nutr 3 2012 286 294
32. B. Laferrere, J. Teixeira, and J. McGinty et al. Effect of weight loss by gastric bypass surgery versus hypocaloric diet on glucose and incretin levels in patients with type 2 diabetes J Clin Endocrinol Metab 93 2008 2479 2485
33. B. Laferrere, S. Heshka, and K. Wang et al. Incretin levels and effect are markedly enhanced 1 month after Roux-en-Y gastric bypass surgery in obese patients with type 2 diabetes Diabetes Care 30 2007 1709 1716
34. Y. Falken, P.M. Hellstrom, and J.J. Holst et al. Changes in glucose homeostasis after Roux-en-Y gastric bypass surgery for obesity at day three, two months, and one year after surgery: role of gut peptides J Clin Endocrinol Metab 96 2011 2227 2235
35. N.B. Jorgensen, C. Dirksen, and K.N. Bojsen-Moller et al. The exaggerated glucagon-like peptide-1 response is important for the improved beta-cell function and glucose tolerance after Roux-en-Y gastric bypass in patients with type 2 diabetes Diabetes 62 2013 3044 3052
36. G. Toffolo, R. Basu, and C. Dalla Man et al. Assessment of postprandial glucose metabolism: conventional dual- vs. triple-tracer method Am J Physiol Endocrinol Metab 291 2006 E800 E806
37. A. Gastaldelli, A. Casolaro, and M. Pettiti et al. Effect of pioglitazone on the metabolic and hormonal response to a mixed meal in type II diabetes Clin Pharmacol Ther 81 2007 205 212
38. H. Sigstad A clinical diagnostic index in the diagnosis of the dumping syndrome. Changes in plasma volume and blood sugar after a test meal Acta Med Scand 188 1970 479 486